MedPath

Evaluation of the preventive effect of intravenous flurbiprofen axetil against mesenteric traction syndrome by continuous measurement of systemic vascular resistance index using a FloTrac sensor.

Not Applicable
Conditions
patients scheduled for elective open abdominal surgery
Registration Number
JPRN-UMIN000007782
Lead Sponsor
Daiyukai General Hospital Dep of Anesthesia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Patient who is taking any steroidal or non-steroidal anti-inflammatory drug (NSAID) that might influence COX activities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
If mesenteric traction syndrome (MTS) occurs, a decline of the systemic vascular resistance (SVR) will be observed. If MTS can be prevented, SVR will be maintained.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath